| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich existing transmission-to-others claim is being transferred?Required |
The selected claim is reduced transmission to other people, with original subclaim grade ? and the note that this was not measured by the trial. Absent subclaim score/status/axes are separated from parent D34 and axes. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Selected wording/subclaim grade versus parent wearer results |
Materials needed: Direct transmission population/endpoints, contact/cluster denominators, comparison/period and existing boundary review. Parent scores are not filled into the subclaim. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 2 |
Unverified |
Full text not readStored summary read |
N02 · Evidence conditionAre wearer protection and source control directly distinguished?Required |
Existing Korean/English reader answers explicitly state that transmission/source control and mandates were not tested. Null wearer infection is not transferred to zero/null or positive transmission effects. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Infection acquired by the wearer versus transmission to others |
Materials needed: Infection sources/contacts, transmission direction/ascertainment, direct cluster/network/contact tracing, denominators/effects/CI. Unmeasured is not changed to zero transmission events. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWas the intervention enforced or verified actual wearing?Required |
The original intervention recommended masks to community adults and supplied 50 surgical masks/instructions. This differs from full actual wearing, mandates or effects of all mask types. Research intervention identification does not provide use/infection-prevention instructions. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Surgical-mask recommendation, 50 masks and instructions |
Materials needed: Original recommendation/distribution, actual use/adherence, product identity/masks and concurrent exposure. No new wearer-adherence or transmission effects are calculated. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat were the control and prevailing advice in both groups?Required |
Original materials record 3,030 assigned to recommendations, 2,994 to control, with both groups following prevailing advice. Actual control mask use/contact/behavior/exposure details remain unverified. This is not relabeled as comparison with no preventive exposure. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Recommendation versus control and common public-health advice |
Materials needed: Actual group masks/contacts/public-health exposure, contamination, expectations/behavior and adherence. Contributions beyond recommendation differences are not newly established. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionWhich period, setting and population were studied?Required |
The original trial involved community adults in 2020 Denmark, where mask use was uncommon. It is not extended to healthcare, other variants/epidemics, mandates or other populations. Eligibility/infection history/baseline/exposure details remain unverified. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
2020 Danish community and uncommon mask use |
Materials needed: Direct transmission materials with eligibility, location/period/epidemic, baseline/contact/concurrent exposure. This is not converted to current mask/infection-prevention guidance. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 6 |
Unverified |
Full text not readStored summary read |
N06 · Evidence conditionWas one-month follow-up long-term observation of transmission networks?Required |
Original follow-up was one month. Direct contact/cluster, infection-source/secondary-transmission timing/observation materials are absent. Wearer duration does not fill valid transmission follow-up or long-term effects. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
One-month wearer follow-up versus contact observation |
Materials needed: Direct infection-source/contact enrollment, exposure/incubation/follow-up/testing, time denominators and losses. No new time/day calculations. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionAre allocation, complete-case analysis and missingness separated?Required |
Preserve 6,024 allocated (3,030/2,994), 4,862 primary complete cases (2,392/2,470) and 19.3% missingness. Allocation/observation/analysis and other-person/contact denominators differ. No new dropout counts/group missingness rates. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
6,024, 4,862 and 19.3% |
Materials needed: Flow, group completion/missingness/testing, reasons/handling/sensitivity and contact denominators. Complete-case results do not certify ITT for everyone or outcomes in others. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionWhat ascertainment methods define wearer infection?Required |
The original endpoint is the wearer’s own one-month SARS-CoV-2 infection by antibody testing, PCR or hospital diagnosis. It is not substituted with PCR alone, test counts, repeated events in the same person or confirmed transmission to others. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
One-month infection by antibody testing, PCR or hospital diagnosis |
Materials needed: Original ascertainment/event definitions, test selection/omissions, baseline/repetition, denominators and infection-source linkage. Endpoint components are not summed as new infections/participants. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionWhich outcome do the wearer effects/CI describe?Required |
Original primary results: 42/2,392(1.8%) versus 53/2,470(2.1%); absolute difference −0.3 percentage points (CI −1.2–0.4), P=.38; OR 0.82 (CI 0.54–1.23), P=.33. Keep effects/P separate without copying them as transmission values. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
42/2392 versus 53/2470, difference and OR |
Materials needed: Original estimands, denominators, models/tests, rounding/intervals and direct transmission effects/CI. No RR/risk-difference/CI recalculation. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionAre self-reported adherence and actual-wearing effects distinguished?Required |
Original self-reports were 46% as recommended, 47% predominantly and 7% not as recommended. Adherence-group denominators/effects and actual exposure details remain unverified. Recommendations are not relabeled as full-wearing/transmission effects, and low adherence is not newly established as the cause of null results. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
46%/47%/7% versus recommendation effects |
Materials needed: Adherence definitions, measurement/exposure/missingness, actual group use/contacts and prespecified adherence analyses. No new counts/rates/adherence effects. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionAre null/wide-CI wearer results separated from unmeasured transmission?Required |
Existing reasons state that the CI retains substantial benefit/harm and does not establish no effect. This concerns wearer uncertainty; transmission was directly unmeasured. No new zero/equivalence or transmission-harms verdict. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Intervals for possible wearer effects versus selected-question gaps |
Materials needed: Original wearer denominators/CI/models/importance and separate direct transmission comparisons. Parent D does not overwrite the transmission subclaim as D. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 12 |
Unverified |
Full text not readStored summary read |
N12 · Evidence conditionAre contact/cluster/network denominators known?Required |
Because transmission was not measured, direct infection-source/contact/household/cluster/network event/exposure denominators are not provided. The 6,024-person wearer allocation count is not used as a contact/transmission-event denominator. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Direct-transmission populations at risk and event denominators |
Materials needed: Direct-transmission design clusters/contacts, enrollment/testing/exposure/ascertainment, secondary events/denominators and correlation/censoring. No new transmission rates, person counts or network values. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 13 |
Unverified |
Full text not readStored summary read |
N13 · Evidence conditionAre indirect source-control indicators used to fill the gap?Required |
The original trial concerns wearer infection and does not answer source control/transmission. Wearer OR/adherence, instructions or mechanistic plausibility do not establish direct transmission effects. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Direct secondary infection versus wearer/mechanistic outcomes |
Materials needed: Infection-source/contact ascertainment, transmission direction/timing/exposure and direct secondary infection/effects/CI. Materials distinguishing viral shedding/mechanisms from clinical transmission. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 14 |
Unverified |
Full text not readStored summary read |
N14 · Evidence conditionAre mandates, healthcare and other epidemics separate questions?Required |
Existing advertising interpretation excludes extension to transmission, mandates, healthcare and other variants/epidemics. Recommendation/behavior/cluster-policy effects are not equated without direct materials. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Applicability boundaries of a recommendation trial |
Materials needed: Direct setting/policy populations, interventions/comparators, transmission/infection, cluster/time denominators and effects/CI. No recommendation/mandate/infection-prevention instructions. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionAre original unblinded, complete-case and missing-data limitations preserved?Required |
The original design is a nationwide unblinded RCT; the parent records complete-case analysis, 19.3% missingness and one-month follow-up limitations. Concealment/exposure changes, measurement/selection/missing-data handling remain unverified. No official RoB review or new bias grade. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Recommendation-trial design and measurement/analysis gaps |
Materials needed: Allocation/behavior/expectations, tests/omissions, missingness/sensitivity and analyses. Original B2 is parent context, not certified transmission review. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionAre original registration start/posting times preserved?Required |
Existing research wording records start 2020-04-02, first posting 2020-04-08 and six-day retrospective registration. Only original dates/wording are retained; current registration versions/endpoints/plans were not externally compared. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
NCT04337541 and six-day retrospective registration |
Materials needed: Actual registration/protocol/SAP versions, availability/changes, primary/secondary outcomes and denominators/analyses. Original six days is not a new calculation or certification. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 17 |
Unverified |
Full text not readStored summary read |
N17 · Harm-information gaps supplementing the efficacy tableWere mask harms directly quantified?Supplementary |
Existing safety wording explicitly states that mask harms were not quantified and does not establish absence of discomfort/skin irritation. Unassessed is not confirmed as zero events, harmlessness or transmission-harms effects. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Discomfort/skin irritation and original lack of harms assessment |
Materials needed: Actual group wearing/exposure, harms collection/denominators, discomfort/skin reactions/discontinuation, relatedness and long-term materials. No mask-use/infection-prevention-care instructions. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat materials were actually read or acquired?Required |
The complete parent summary was read for production and preserved in its original form. Summary reading concerns preserved materials; external abstracts/full texts/registrations/protocols/SAP remain unread. Original citations/URLs do not establish external reading here. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Preserved summary versus external materials |
Materials needed: Records of actual acquisition/reading scope, versions and dates. No external-link/click/access testing. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionAre historical registration/prespecification and current reading separated?Required |
Preserve original NCT04337541, start 2020-04-02/first posting 2020-04-08 and six-day retrospective-registration wording. Actual versions/plans/access remain unread here; official URLs are not guessed. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Original registration identifier, timing and plans |
Materials needed: Actual registration versions/availability, recruitment/start/changes, endpoints/models/analyses and original-report linkage. Only history is preserved, with no current plan/prespecification certification. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 20 |
Unverified |
Full text not readStored summary read |
N20 · Evidence conditionHave protocol/SAP and analysis/missing-data plans been acquired?Required |
Original primary/analysis/registration wording and historical cross-validation are preserved. Actual protocol/SAP, versions/timing, endpoint-specific models/missingness and hierarchy/multiplicity were not read here. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Separate materials for prespecified plans/changes |
Materials needed: Original protocol/SAP/revisions, estimands/denominators/analyses, all endpoints and availability timing. Unread is not declared document absence. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionAre sponsorship/funding, products, authors and research roles separated?Required |
Preserve Salling Foundations funding, Rigshospitalet leadership and study-supplied masks. Manufacturer donation/medical-writing/publication-cost support was not verified in the original; company funding, employee authors and design/analysis roles remain separately unverified. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Four company-involvement items and institution/foundation support |
Materials needed: Individual original company cash funding, product support, employee authors/outside relationships, design/analysis/data control and other institutional support. Original I2 is not new certification of all items/independence. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionAre directly unmeasured, null and unverified outcomes distinguished?Required |
Distinguish null wearer infection/wide CI from directly unmeasured transmission, absent contact denominators and unread details. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Question/results versus access gaps |
Materials needed: Original direct-measurement/endpoint tables, estimands/denominators, plans and actual-access records. Unread is not unreported, and null is not exactly zero/equivalence. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionAre reports, trials, people, tests/timepoints and sibling sheets separated?Required |
Parent 2971 and existing s0/s1 share the same DANMASK-19 report, 6,024 allocated and 4,862 complete cases. People/groups/tests/events/timepoints/bibliographies/sibling sheets are not summed as independent trials/participants; wearer denominators do not fill other-person denominators. Linked-report counts do not certify unique totals. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Linked records versus unique trials/participants |
Materials needed: Original report/registration, cohort/test/timepoint, event/repetition/observation and overlap relationships. Unique trials/participant totals remain not recorded. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Evidence conditionAre the original single trial and separate replication distinguished?Supplementary |
Preserve parent R1/I2 and the single-trial scope. Timepoints/endpoints in the same people and sibling sheets do not certify new independent replication. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Parent R1/I2, follow-up and confirmation |
Materials needed: Separate prespecified direct population/intervention/comparator/endpoint/period, denominators/effects/CI and disclosed funding/author relationships for the selected question. No new search/independence judgment. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionAre the subclaim grade and parent score/axes preserved?Required |
Preserve selected grade/note and both question languages. Absent subclaim score/status/axes remain not recorded. Parent D34, safety and axes are parent context and are not transferred as a selected score. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Selected ? grade, absent subclaim values and parent D34 |
Materials needed: Existing subclaim/parent-boundary review and actual correction materials. No new grade/score or official RoB 2/GRADE certification. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionAre both languages, citations and absent fields preserved?Required |
Preserve parent Korean/English citations/descriptions, evidence/citation lists, axes and selected-subclaim records in the complete summary. Separate classification information in both languages is absent; originals are not filled with new fields. No external English full-text comparison. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Both original languages and absent separate classification information |
Materials needed: Review materials for terminology, endpoints/effects/test units, selected scope and absent fields in both languages. Production explanations are distinguished from original records. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionAre source dates/corrections/history separated from production dates?Required |
Preserve original 2026-08-26, empty corrections/deliberation and verdict-decision cross-validation. Original citation/registration wording differs from current production/condition freezing/application or completed content review. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Original 2026-08-26 and new conditions/application |
Materials needed: Update materials separating originals, events, conditions/observations and verdict decisions when new evidence/corrections arise. Historical wording is not completed clinical content review here. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionWhat direct materials would fill the selected gaps?Supplementary |
Transmission gaps require direct infection-source/contact/cluster/network ascertainment/observation and effects/CI. Null one-month wearer results or mechanisms do not substitute for them. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Direct endpoints, estimands/CI and denominators/follow-up |
Materials needed: Original tables/plans, direct populations/comparators/endpoints, estimands/CI, observation/tests/denominators, actual exposure/adherence, separate confirmation and long-term harms. Only needs are recorded; no new search/research. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionAre applicability records separated from content review and instructions?Supplementary |
These are summary-based applicability records. Existing content/question-boundary review remains incomplete; candidate pending/eligible markers are preserved as history. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Applicability records, existing candidate history and content review |
Materials needed: Existing content review and later actual-material/correction work. Historical production did not perform clinical original-material comparison, external access, new calculations, grade changes or mask/infection-prevention/treatment-replacement instructions. Only material requests/research needs are recorded; no search or research was performed in that production. |